In 2015, Tuszynski et al. reported trophic response to NGF gene therapy in AD in the form of axonal sprouting and neurons exhibit tau free expression of NGF indicating the therapeutic genes leads to activation of cell signaling in AD [84]. The gene discussed is MAPT; the disease is Alzheimer disease.